Short-Term Efficacy and Safety of Repaglinide Versus Glimepiride as Augmentation of Metformin in Treating Patients With Type 2 Diabetes Mellitus

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy - New Zealand

doi 10.2147/dmso.s198154